Basic/Translational Research Training for CHP Pediatric Fellows
Basic/Translational Research Training for CHP Pediatric Fellows
批准号:
8467258
负责人:
David H Perlmutter
金额:
$20.21万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-05-01 至 2018-04-30
中文摘要
描述(由申请人提供):这是一个申请,以重新建立一个导师培训计划的儿科专科研究员感兴趣的研究职业生涯涉及基础或翻译研究。该项目提供为期两年的细胞/分子生物学或与儿童健康相关的转化研究方面的培训,每人4名研究员。
年,旨在作为职业生涯的起点,最终成为NIH R01资助的儿科内科科学家。该计划的主要特点之一是,它可用于培训匹兹堡大学儿科系内没有T32补助金的若干子专业的研究员(过敏/免疫学;心脏病学;遗传学;血液学/肿瘤学;传染病;新生儿医学;肺病学)。因此,它可以通过瞄准最有才华的研究员并将他们与杰出的导师相匹配来最大限度地获得校外支持。指导人员包括25名杰出的研究人员,他们在研究贡献和指导方面有着杰出的记录。这种指导经验的哲学重点是科学方法的基本原理与严谨和诚信的最高标准相结合,因为我们相信这些是培训经验的特征,最有可能导致长期成功的职业生涯每个学者都希望在其中一名教师导师的实验室中开展具有挑战性的研究项目,导致出版物以及他们自己的K08、K23或K99/R00补助金的申请。皮特大学儿科系拥有全国增长最快的儿科研究项目之一,以匹兹堡儿童医院的新校区为基础,拥有占地300,000平方英尺的CHP Rangos儿科研究大楼。基于这些特点和我们之前的培训结果,我们相信这个项目提供了一个强大的导师团队和丰富的智力环境,将激励儿科专科研究员,并为他们提供成为成功的儿童健康研究人员的背景。
英文摘要
DESCRIPTION (provided by applicant): This is an application to re-establish a mentored training program for pediatric subspecialty fellows interested in research careers involving basic or translational research. The program offers a 2-year experience dedicated to training in cell/molecular biology or translational research that is relevant to child health for 4 fellows per
year and is designed to serve as a launch for a career that ultimately as an NIH R01-funded pediatric physician scientist. One of the key features of this program is that is can be used for training of fellows in a number of subspecialties within the Department of Pediatrics of the University of Pittsburgh that do not have a T32 grant (Allergy/Immunology; Cardiology; Genetics; Hematology/Oncology; Infectious Diseases; Newborn Medicine; Pulmonology). Thus, it can maximize the extramural support by targeting the most talented fellows and matching them with outstanding mentors. The mentoring faculty includes 25 outstanding researchers who have a distinguished record of research contributions and mentoring. The philosophical emphasis of this mentoring experience is fundamentals of the scientific method combined with the highest standard of excellence for rigor and integrity because we believe these are the characteristics of the training experience that are most likely to lead to a long successful career Each of the Scholars is expected to carry out a challenging research project in the laboratory of one of the faculty mentors leading to publications as well as an application for their own K08, K23 or K99/R00 grant. The Department of Pediatrics at Pitt has one of the fastest growing pediatric research programs in the country and is based on a new Children's Hospital of Pittsburgh of UPMC campus with the new 300,000-square-foot CHP Rangos Pediatric Research Building. Based on these characteristics and our previous training results, we believe that this program provides a powerful team of mentors and intellectually-rich environment that will inspire pediatric subspecialty fellows and provide them with the background to become successful child health researchers.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Novel therapies that target mitochondrial dysfunction for treatment of a1-antitrypsin deficiency liver disease
-
批准号:10342938
-
项目类别:
-
资助金额:$66.31万
-
财政年份:2021
-
负责人:David H Perlmutter
-
依托单位:
Novel therapies that target mitochondrial dysfunction for treatment of a1-antitrypsin deficiency liver disease
-
批准号:10541910
-
项目类别:
-
资助金额:$62.36万
-
财政年份:2021
-
负责人:David H Perlmutter
-
依托单位:
Signaling Pathways Influencing Liver Disease Phenotype in Antitrypsin Deficiency
-
批准号:9180521
-
项目类别:
-
资助金额:$46.08万
-
财政年份:2016
-
负责人:David H Perlmutter
-
依托单位:
Signaling Pathways Influencing Liver Disease Phenotype in Antitrypsin Deficiency
-
批准号:9251285
-
项目类别:
-
资助金额:$45.24万
-
财政年份:2016
-
负责人:David H Perlmutter
-
依托单位:
Signaling pathways influencing liver disease phenotype in antitrypsin deficiency
-
批准号:8608884
-
项目类别:
-
资助金额:$45.55万
-
财政年份:2014
-
负责人:David H Perlmutter
-
依托单位:
Basic/Translational Research Training for CHP Pediatric Fellows
-
批准号:8626425
-
项目类别:
-
资助金额:$35.01万
-
财政年份:2013
-
负责人:David H Perlmutter
-
依托单位:
New Therapies for Liver Fibrosis and Hyperproliferation in Alpha1-AT Deficiency
-
批准号:10441250
-
项目类别:
-
资助金额:$187.69万
-
财政年份:2012
-
负责人:David H Perlmutter
-
依托单位:
New therapies for liver fibrosis and hyperproliferation in alpha1-AT deficiency
-
批准号:8921978
-
项目类别:
-
资助金额:$180.31万
-
财政年份:2012
-
负责人:David H Perlmutter
-
依托单位:
New Therapies for Liver Fibrosis and Hyperproliferation in Alpha1-AT Deficiency
-
批准号:10197888
-
项目类别:
-
资助金额:$190.52万
-
财政年份:2012
-
负责人:David H Perlmutter
-
依托单位:
Treating AT Deficiency with Drugs that Modulate the Proteostasis Network
-
批准号:10197891
-
项目类别:
-
资助金额:$41.8万
-
财政年份:2012
-
负责人:David H Perlmutter
-
依托单位:
Treating AT Deficiency with Drugs that Modulate the Proteostasis Network
-
批准号:10630354
-
项目类别:
-
资助金额:$40.2万
-
财政年份:2012
-
负责人:David H Perlmutter
-
依托单位:
New therapies for liver fibrosis and hyperproliferation in alpha1-AT deficiency
-
批准号:9125817
-
项目类别:
-
资助金额:$147.9万
-
财政年份:2012
-
负责人:David H Perlmutter
-
依托单位:
Treating AT Deficiency with Drugs that Modulate the Proteostasis Network
-
批准号:10441253
-
项目类别:
-
资助金额:$41.04万
-
财政年份:2012
-
负责人:David H Perlmutter
-
依托单位:
New therapies for liver fibrosis and hyperproliferation in alpha1-AT deficiency
-
批准号:8720758
-
项目类别:
-
资助金额:$183.33万
-
财政年份:2012
-
负责人:David H Perlmutter
-
依托单位:
New Therapies for Liver Fibrosis and Hyperproliferation in Alpha1-AT Deficiency
-
批准号:10630349
-
项目类别:
-
资助金额:$184.87万
-
财政年份:2012
-
负责人:David H Perlmutter
-
依托单位:
Treating AT deficiency with drugs that modulate the proteoatasis network
-
批准号:8464402
-
项目类别:
-
资助金额:$27.06万
-
财政年份:2012
-
负责人:David H Perlmutter
-
依托单位:
New therapies for liver fibrosis and hyperproliferation in alpha1-AT deficiency
-
批准号:8548327
-
项目类别:
-
资助金额:$178.68万
-
财政年份:2012
-
负责人:David H Perlmutter
-
依托单位:
New therapies for liver fibrosis and hyperproliferation in alpha1-AT deficiency
-
批准号:8413946
-
项目类别:
-
资助金额:$189.4万
-
财政年份:2012
-
负责人:David H Perlmutter
-
依托单位:
Carbamazepine for severe liver disease due to antitrypsin deficiency
-
批准号:8323928
-
项目类别:
-
资助金额:$22.73万
-
财政年份:2011
-
负责人:David H Perlmutter
-
依托单位:
Therapeutic Use of Autophagy Enhancer Drugs for Alzheimer's Disease
-
批准号:8174171
-
项目类别:
-
资助金额:$19.32万
-
财政年份:2011
-
负责人:David H Perlmutter
-
依托单位:
海外基金